Australian insurer QBE beats interim profit estimates on premium growth, lower claims
The company said its catastrophe costs stayed below its allowance despite high industry losses from severe U.S. and Australian weather, including floods in the Mid-North Coast and in the Hunter regions onshore in May.
The group paid out $479 million in catastrophe-related claims, lower than $527 million forked out in the prior corresponding period and "comfortably below" its first-half catastrophe allowance of $549 million.
The group, which operates in 27 countries including the United States, said its gross written premiums grew 5.9% to $13.82 billion for the first half of fiscal 2025.
The insurer added that growth continued, fuelled by targeted expansion in select insurance classes in North America and internationally, and aided by reduced costs after exiting weaker lines.
QBE posted adjusted net profit after income tax of $997 million for the six months ending June 30, compared with $777 million a year earlier, beating LSEG estimate of $839.39 million.
The Sydney-based insurer also declared an interim dividend of 31 Australian cents per share, up from 24 Australian cents a year ago.
The company reported a combined operating ratio of 92.8%, compared with 93.8% a year earlier. A ratio below 100% means the insurer earned more in premiums than it paid out in claims.
QBE reiterated its forecast for constant currency gross written premiums growth in mid-single digits for financial year 2025.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
20 minutes ago
- Yahoo
Clinical Trial Biorepository and Archiving Solutions Market Size Expected to Attain USD 9.69 Billion by 2034
The global clinical trial biorepository and archiving solutions market is valued at USD 4.76 billion in 2025 and is projected to reach approximately USD 9.69 billion by 2034, expanding at a CAGR of 8.21% during the forecast period, according to a study published by Towards Healthcare, a sister company of Precedence Research. Ottawa, Aug. 19, 2025 (GLOBE NEWSWIRE) -- The global clinical trial biorepository and archiving solutions market was valued at USD 4.4 billion in 2024 and is projected to reach approximately USD 9.69 billion by 2034, expanding at a CAGR of 8.21%. The market is fueled by accelerating research and development in different fields of healthcare. The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report @ Key Takeaways North America was dominant in the clinical trial biorepository and archiving solutions market by 49% shares in 2024. Asia Pacific is expected to grow at the fastest CAGR during 2025-2034. By service, the biorepository services segment led the market in 2024. By service, the archiving solution services segment is expected to grow notably in the upcoming years. By product, the clinical products segment dominated the clinical trial biorepository and archiving solutions market in 2024. By product, the preclinical products segment is expected to grow at a notable CAGR in the studied years. By phase, the preclinical segment registered dominance in the market in 2024. By phase, the phase II segment is expected to grow at a rapid CAGR during 2025-2034. Market Overview & Potential Primarily, the clinical trial biorepository and archiving solutions market comprises the secure storage and management of biological samples (like blood, tissue, and DNA) and linked data from clinical trials. Alongside, it has widespread application in various areas, like clinical research, pharmaceutical development, and personalized medicine, with the increasing focus on data integrity and regulatory compliance. Apart from this, expanding data management, optimizing sample storage, and enhancing the use of digital solutions for compliance and collaboration are propelling the overall adoption and expansion of clinical trial biorepository and archiving solutions. What are the Major Growth Drivers Involved in The Growth of The Market? The clinical trial biorepository and archiving solutions market is driven by continuous groundbreakings in biobanking technologies, like automation and data analytics, which are boosting the effectiveness and accuracy of biorepository operations. Along with this, the widespread application of centralized biorepositories and cloud-based archiving solutions possesses greater accessibility, collaboration, and data management is also impacting the overall market development. You can place an order or ask any questions, please feel free to contact us at sales@ What are the Key Trends Associated with the Market? The clinical trial biorepository and archiving solutions market is developing due to the requirement for efficient sample management, regulatory guidelines for data integrity, and the growing demand for personalized medicine and genomic research. In February 2025, Charles River and Deciphex extended their global partnership to progress digital pathology offering with exclusive image management solutions. In January 2025, Moffitt Cancer Center, a leading National Cancer Institute-designated comprehensive cancer center, and Cryoport, Inc., a global company in supply chain solutions for the life sciences industry, collaborated to offer CRYOGENE's state-of-the-art biorepository services to Speros in Pasco County, Florida. What is the Arising Challenge in the Market? In the clinical trial biorepository and archiving solutions market, accelerating expenses for the establishment and maintenance of biorepositories are essential. Moreover, this needs wide-range investments in infrastructure technology, such as temperature-controlled storage, as well as participation of specialized personnel are also creating barriers in the market expansion. Eventually, small-scale and emerging organizations may experience these hurdles in their development. Regional Analysis Become a valued research partner with us - How Did North America Dominate the Market in 2024? In 2024, North America held the biggest revenue share of 49% in the clinical trial biorepository and archiving solutions market. This region fosters an advanced pharmaceutical sector, with numerous clinical trials, and a phenomenal network of biobanks and research institutions. Along with this, major investments in the R&D department by leading players in the US and Canada are boosting the comprehensive development. Apart from this, the US FDA's stricter regulatory landscape enables adequate biorepository solutions for sample and data May 2025, Cybin Inc., a clinical-stage advanced neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, announced its participation in the Alliance Global Partners Healthcare Company Showcase. In January 2025, ONCare Alliance and partnered to develop a multi-omics database and biobank to accelerate biomarker discovery in oncology. What to Expect from Asian Countries in Clinical Trial Biorespository and Archiving Solutions Market? Asia Pacific is anticipated to grow at the fastest CAGR in the clinical trial biorepository and archiving solutions market. Several eminent companies of ASAP countries like China, India, and Japan, resulting in a higher demand for specialized biorepository and archiving solutions. Furthermore, they are supporting the development rigorous clinical trials platform globally. Besides this, ongoing advances in biobanking technologies, especially automated sample handling, cryopreservation techniques, and digital archiving, are optimizing the efficiency and reliability of biorepository solutions. For instance, In June 2025, iNGENū CRO entered into a partnership with Quantum BioPharma to launch a pioneering Australian clinical trial for chronic nociplastic pain in MCAS patients. In February 2025, LabConnect and Australian Clinical Labs' (ACL) Specialised Trials forged a strategic collaboration to boost support of clinical trials in Australia and the Asia-Pacific region. Get the latest insights on healthcare industry segmentation with our Annual Membership: Segmental Insights By Service Analysis Why did the Biorepository Services Segment Lead the Market in 2024? The biorepository services segment held a dominating share of the clinical trial biorepository and archiving solutions market in 2024. Primarily, the segment is propelled by the wider demand for biorepository services in oncology research and customized medicine. Along with this, these services are increasingly merged in the safe and secure storage of biological samples, which are vital for biomarker discovery, treatment response analysis, and targeted therapy development. Whereas, various biorepositories are termed as biosample libraries, providing valuable resources for studies focused on enhancing individual patient care and advancing medical knowledge. Although the archiving solution services segment is predicted to expand at a significant CAGR during 2025-2034. This service plays a prominent role in the maintenance of comprehensive patient records and the facilitation of access to historical medical data, which is necessary for precise diagnoses and efficient healthcare delivery. They also manage a large volume of data during clinical trials, comprising lab results, patient records, and imaging data, ensuring data integrity and accessibility. In the security of significant biological samples and data, these services are acting as a major component in the research findings. By Product Analysis How did the Clinical Products Segment Hold the Largest Share of the Market in 2024? In 2024, the clinical products segment led the clinical trial biorepository and archiving solutions market. This segment mainly encompasses diverse products, such as cryogenic vials, tubes, and other containers designed for long-term preservation of biological samples, as well as barcodes, RFID tags, and software to track samples throughout the trial lifecycle. Additionally, specialized containers and equipment for sample handling are important in early-stage research. Also, these kinds of products provide the maintenance of sample viability, prevention of degradation, and allowance for accurate analysis. However, the preclinical products segment will expand significantly during 2025-2034. Across the globe, various ongoing preclinical studies that need strong sample management for toxicology and genetic analysis fuel the demand for advanced biorepository and archiving systems. As well as preclinical biorepositories, it provides controlled environments, including temperature, humidity, etc., to control the integrity of biological samples, such as tissues, cells, and blood, which are major aspects for accurate analysis and validation. Preclinical products usually consist of different technologies and methodologies for processing and preserving samples, maintaining their quality for downstream analysis. This further expands the drug development process. By Phase Analysis How did the Preclinical Segment Dominate the Market in 2024? In the clinical trial biorepository and archiving solutions market, the preclinical segment captured a major revenue share in 2024. The segment is driven by a rise in R&D spending by numerous biopharmaceutical companies, which is resulting in greater preclinical studies and an enhanced need for trustworthy biorepository and archiving solutions. Nowadays, the preclinical studies are widely employed in the growing development of precision medicine, extensive sample analysis. The phase II segment is anticipated to expand rapidly in the coming years. This phase is related to the study of a drug's efficacy, safety, and potential side effects, which requires meticulous archived and connecting with the corresponding biological samples. During this phase, diverse biological samples, like blood, tissue, and other biospecimens, are collected with the application of biorepositories for their storage. Moreover, the segment is impacted by strict regulatory rules for clinical trials, such as those regarding data integrity and sample preservation, which also propel the need for reliable biorepository and archiving solutions. Browse More Insights of Towards Healthcare: The clinical trial investigative site network market was valued at USD 8.36 billion in 2023 and is projected to reach USD 15.99 billion by 2034, expanding at a CAGR of 6.07% from 2024 to 2034. The global cell and gene therapy clinical trials market stood at USD 10.8 billion in 2024, increased to USD 12.47 billion in 2025, and is expected to climb to USD 45.31 billion by 2034, registering a strong CAGR of 15.43% during 2025–2034. The clinical genomics market was valued at USD 1.06 billion in 2024, grew to USD 1.25 billion in 2025, and is anticipated to reach USD 5.34 billion by 2034, expanding at a CAGR of 17.54% between 2025 and 2034. The preclinical advanced cell models market is witnessing strong momentum and is set to generate substantial revenues, with estimates indicating growth into the hundreds of millions by 2034. The AI in clinical trials for drugs market is also on a robust growth path, projected to achieve significant revenue gains, potentially reaching into the hundreds of millions from 2025 to 2034. The clinical data analytics market was valued at USD 81.65 billion in 2024, rose to USD 104.16 billion in 2025, and is forecasted to surge to USD 930.01 billion by 2034, reflecting an impressive CAGR of 27.57% between 2025 and 2034. The clinical trial design market stood at USD 567.66 million in 2024, grew to USD 613.25 million in 2025, and is projected to reach USD 1,228.57 million by 2034, expanding at a CAGR of 8.04% from 2025 to 2034. The preclinical CRO market was valued at USD 6.8 billion in 2025 and is expected to grow to USD 14.34 billion by 2034, advancing at a CAGR of 8.73% during 2025–2034. The core clinical molecular diagnostics market was estimated at USD 5.3 billion in 2023 and is set to reach USD 14.45 billion by 2034, growing at a CAGR of 9.54% between 2024 and 2034. The decentralized clinical trials (DCTs) market stood at USD 8.29 billion in 2023 and is forecasted to rise to USD 38.2 billion by 2034, with a CAGR of 14.9% from 2024 to 2034. Recent Developments In August 2025, Union Minister Dr. Jitendra Singh launched the country's first Animal Stem Cell Biobank at the National Institute of Animal Biotechnology (NIAB), equipped with 3D bioprinting, advanced cryostorage. In May 2025, Sapio Sciences unveiled an innovative Biorepository Management solution, with accelerated sample management capabilities and platform-wide improvements created to simplify lab operations and support high-throughput research environments. In May 2025, Markel Insurance, the insurance operations within Markel Group Inc., launched its Clinical Trials insurance product to provide best-in-class solutions to assist clinical trials research and product development on an international scale. In April 2025, Axtria Inc., an AI-first data analytics innovator transforming life sciences, introduced LUCCID, short for LLM-based Unstructured Clinical Concept Identification, a novel GenAI-powered solution. In January 2025, Stoke Therapeutics announced alignment with global regulatory agencies and plans to initiate a phase 3 study of Zorevunersen as probably the foremost disease-modifying medicine for the treatment of Dravet syndrome. Clinical Trial Biorepository and Archiving Solutions Market Key Players Medpace American Type Culture Collection (ATCC) Cell&Co BioServices (Cryoport) Brooks Life Sciences (Azenta, Inc.) Patheon (Thermo Fisher Scientific, Inc.) Precision Medicine Group, LLC. Labcorp Drug Development Q2 Solutions LabConnect Charles River Laboratories Segments Covered in The Report By Service Biorepository Services Warehousing & storage Transportation Sample Processing Others Archiving Solution Services Database Indexing and Management Scanning & Destruction By Product Preclinical Products Clinical Products Human Tissue Organs Stem cells Other Biospecimens By Phase Preclinical Phase I Phase II Phase III Phase IV By Region North America U.S. Canada Asia Pacific China Japan India South Korea Thailand Europe Germany UK France Italy Spain Sweden Denmark Norway Latin America Brazil Mexico Argentina Middle East and Africa (MEA) South Africa UAE Saudi Arabia Kuwait To invest in our premium strategic solution and customized market report options, click here: You can place an order or ask any questions, please feel free to contact us at sales@ Access our exclusive, data-rich dashboard dedicated to the healthcare market - built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway. Access the Dashboard: About Us Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research. Dedicated to advancing innovation in the life sciences sector, we build strategic partnerships that generate actionable insights and transformative breakthroughs. As a global strategy consulting firm, we empower life science leaders to gain a competitive edge, drive research excellence, and accelerate sustainable growth. Our Trusted Data Partners Precedence Research | Statifacts | Towards Packaging | Towards Automotive | Towards Food and Beverages | Towards Chemical and Materials | Towards Consumer Goods | Towards Dental | Towards EV Solutions | Nova One Advisor | Healthcare Webwire | Packaging Webwire | Automotive Webwire Find us on social platforms: LinkedIn | Twitter | Instagram | Medium | PinterestError in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
20 minutes ago
- Yahoo
Best Buy Marketplace Launches, Offering Dishes, Instruments, Toys, and More
Key Takeaways Best Buy's third-party marketplace went live in the U.S. on Tuesday. Customers can now purchase cookware, decor, and musical instruments through Best Buy's app and website. The electronics giant is one of several retailers trying to tap into the third-party marketplace business model. You can now go to Best Buy's website for everything from a statue of Ganesh playing the flute to a set of champagne flutes. Best Buy (BBY) doubled the number of products available through its website and app while launching a U.S. marketplace Tuesday that's open to hundreds of brands not carried in its stores, such as Martha Stewart, Crock-Pot, and World Wide Stereo. The marketplace offers more technology and taps into new categories, including sports team merch, seasonal decorations, and musical instruments, as well as toys and puzzles, Best Buy said in a press release and Q&A. 'Our customers have always looked to us to bring excitement and inspiration in ways only technology can,' Frank Bedo, chief marketplace and eCommerce officer at Best Buy, said in a statement. Through the marketplace, 'we can truly offer the full experience they need,' the statement said. The electronics giant, which already has a third-party platform in Canada, is the latest retailer to launch an online marketplace—a move that allows companies to expand their product portfolio without investing in inventory or storage space. Walmart (WMT), Target (TGT), Lowe's (LOW), Nordstrom, and Ulta (ULTA) have launched or shared plans to launch a marketplace, according to company announcements. Digital marketplaces are estimated to facilitate hundreds of billions of dollars in annual sales. Best Buy didn't immediately respond when asked if items not stocked in stores but bought through the marketplace could be shipped to stores for pickup. Marketplace purchases can be returned to stores, the press release said. Best Buy shares were up about 5% in recent trading but are down more than 10% for the year. In late May, the company reported mixed first-quarter results and lowered its full-year outlook because of tariffs. Read the original article on Investopedia Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
20 minutes ago
- Yahoo
Wi-Fi Chipset Market worth $29.86 billion by 2030 - Exclusive Report by MarketsandMarkets™
DELRAY BEACH, Fla., Aug. 19, 2025 /PRNewswire/ -- The global Wi-Fi chipset market is projected to be valued at USD 22.50 billion in 2025 and USD 29.86 billion by 2030, at a CAGR of 5.8% during the forecast period according to a new report by MarketsandMarkets™. The rising popularity of connected devices, such as smartphones, smart TVs, laptops, wearables, and smart home appliances, significantly drives the demand for Wi-Fi chipsets. As consumers and enterprises increasingly adopt IoT solutions and smart ecosystems, reliable and high-speed wireless connectivity becomes essential. This rising need for seamless connectivity is boosting the integration of Wi-Fi chipsets across a wide range of applications. Download PDF Brochure: Browse in-depth TOC on "Wi-Fi Chipset Market" 100 – Tables60 – Figures200 – Pages Wi-Fi Chipset Market Scope: Report Coverage Details Market Revenue in 2025 $ 22.50 billion Estimated Value by 2030 $ 29.86 billion Growth Rate Poised to grow at a CAGR of 5.8% Market Size Available for 2021–2030 Forecast Period 2025–2030 Forecast Units Value (USD Million/Billion) Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends Segments Covered By IEEE Standard, by Band, By MIMO-Configuration, Vertical, End-use Application, and Region Geographies Covered North America, Europe, Asia Pacific, and Rest of World Key Market Challenge Overcrowding of unlicensed wireless frequency spectrum Key Market Opportunities Use of Wi-Fi technology in indoor and outdoor location systems Key Market Drivers Increasing need for faster data transfer 802.11ax (Wi-Fi 6 & 6E) segment is expected to account for largest market share in 2025 The 802.11ax (Wi-Fi 6 & 6E) segment is expected to dominate the market in 2025 due to its superior performance in high-density environments, increased speed, and enhanced network efficiency. Its ability to support multiple users simultaneously with reduced latency makes it ideal for smart homes, enterprise networks, and industrial IoT applications. Growing adoption across consumer electronics and enterprise infrastructure further strengthens its market share. MU-MIMO configuration is projected to witness highest CAGR in Wi-Fi chipset market between 2025 and 2030. The MU-MIMO configuration segment is projected to record the highest CAGR during the forecast period due to its capability to serve multiple devices simultaneously, enhancing network efficiency and user experience. It is increasingly adopted in enterprise networks, smart homes, and public hotspots to manage high data traffic. Its compatibility with advanced Wi-Fi standards, such as Wi-Fi 6 and 7, further drives its demand for use in multiple applications. Inquiry Before Buying: Asia Pacific is estimated to hold the largest market share in Wi-Fi chipset market during the forecast period. Asia Pacific is expected to hold the largest market share in the Wi-Fi chipset industry during the forecast period, driven by rapid digitalization, expanding smartphone and consumer electronics production, and growing internet penetration. Countries like China, India, South Korea, and Japan invest heavily in smart infrastructure and 5G deployment. Additionally, the region's large manufacturing base supports high-volume chipset integration, accelerating market growth. Key Players Key companies operating in the Wi-Fi chipset companies include Qualcomm Technologies, Inc. (US), Broadcom (US), MediaTek (Taiwan, Intel Corporation (US), Realtek Semiconductor Corp. (Taiwan) Infineon Technologies AG (Germany), NXP Semiconductors (Netherlands), Semiconductor Components Industries, LLC (US), Renesas Electronics Corporation (Japan), and Espressif Systems (China). Get 10% Free Customization on this Report: Browse Adjacent Market: Semiconductor and Electronics Market Research Reports &Consulting See More Latest Semiconductor Reports: Al-based Image Analysis Market by Deployment Mode (On-premises, Cloud-based), Technology (Deep Learning, Traditional Machine Learning, Hybrid & Other Al Technologies), End-use Industry and Region - Global Forecast to 2030 Automated Stationary NDT & Inspection Systems Market by in-line System Type, Ultrasonic Testing (UT), Phased Array Ultrasonic Testing (PAUT), Eddy Current Testing (ECT), Metals & Metallurgy, Rail, Oil & Gas, Aerospace - Global Forecast to 2030 About MarketsandMarkets™ MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter , LinkedIn and Facebook . Contact: Mr. Rohan SalgarkarMarketsandMarkets™ INC.1615 South Congress 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: sales@ Our Web Site: Insight: Source: Logo: View original content to download multimedia: SOURCE MarketsandMarkets Sign in to access your portfolio